Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2006
08/24/2006US20060189650 Novel piperidine derivatives as modulators of chemokine receptor ccr5
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors
08/24/2006US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine
08/24/2006US20060189625 Cyclic aminophenyl sulfamate derivative
08/24/2006US20060189567 Compound having affinity with calcified tissue
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
08/24/2006US20060189500 Aqueous olanexidine solution, method of preparing the same, and disinfectant
08/24/2006US20060188953 Methods and compositions that affect melanogenesis
08/24/2006US20060188636 Papaya puree and the use of the same
08/24/2006US20060188557 Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor
08/24/2006CA2598044A1 Cosmetic use of at least one natural ac-n-ser-asp-lys-pro-tetrapeptide or one of its analogues as agent for slowing down loss of hair and/or stimulating hair growth
08/24/2006CA2598017A1 Triazole derivatives
08/24/2006CA2596984A1 Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis
08/24/2006CA2595620A1 Compositions for treatment of diseases of the nail unit
08/24/2006CA2594490A1 Methods of treating skin disorders using an il-31ra antagonist
08/23/2006EP1693382A2 Melanocortin 1 receptor selective compounds
08/23/2006EP1693367A1 Piperidine compound and method for producing same
08/23/2006EP1693073A2 Wound dressings comprising hydrated hydrogels and enzymes
08/23/2006EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis
08/23/2006EP1693065A1 Fibroblast-mobilizing agent containing g-csf and wound remedy
08/23/2006EP1692267A2 Methods of organ regeneration
08/23/2006EP1691806A2 Novel therapeutic method and compositions
08/23/2006EP1624852B1 Sun tanning products and products for treatment of the skin before and after exposure to the sun
08/23/2006EP1432414B1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis
08/23/2006EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases
08/23/2006EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
08/23/2006EP1290939B1 Caspase 1 gene transfer animal
08/23/2006EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist
08/23/2006EP1126837B1 Fulvic acid and its use in the treatment of various conditions
08/23/2006EP1052963B1 Use of alkanoic acid containing compositions for treating nail fungal conditions
08/23/2006CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders
08/23/2006CN1823039A Cyclic aminophenyl sulfamate derivative
08/23/2006CN1823028A Novel dibenzoilmethane derivative compounds, the use thereof in the form of photoactivable solar filters and cosmetic compositions containing said compounds
08/23/2006CN1822853A Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1820645A Danshi food and preparing method
08/23/2006CN1820616A Biological health tea
08/23/2006CN1270776C Ulcer quieting medicine its preparation and use
08/23/2006CN1270770C Polypeptide vaccine capable of effectively preventing pointed condyloma
08/23/2006CN1270767C Medicine for treating vasculitis, scleriasis and arteriosclerosis type lower limb vascular occlusion
08/23/2006CN1270748C Chinese medicinal composition for treating sore and wound infection
08/23/2006CN1270728C use of fetus toxic liquid for preparing baby's skin external products
08/23/2006CN1270725C Inorganic nitrite and organic acid in combination as topical antiviral composition
08/23/2006CN1270713C Synergistic pharmaceutical combination for prevention or treatment of diabetes
08/23/2006CN1270710C Medicinal solution for treating ulceration and inflammation
08/23/2006CN1270705C External essence oil for treating beriberi
08/23/2006CN1270696C Skin nourishing oil and method of preparation the same
08/22/2006US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent
08/22/2006US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
08/22/2006US7094804 Water free ubiquinone concentrate
08/22/2006US7094802 PKB-3564 substance with neovascularization inhibitory activity
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/22/2006US7094797 Organ fibrosis inhibitor
08/22/2006US7094796 Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field
08/22/2006US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders.
08/22/2006US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets
08/22/2006US7094774 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds
08/22/2006US7094773 LTA4 hydrolase inhibitors
08/22/2006US7094569 Polypeptide for use in the treatment and prevention of alopecia
08/22/2006US7094431 Method of healing skin wounds in mammals and a composition therefor
08/22/2006CA2279967C Method of enhancing hair growth
08/22/2006CA2265780C Sulfated polysaccharides and uses thereof in medical treatment
08/22/2006CA2157836C L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
08/18/2006CA2498623A1 Treatment of onychomycosis
08/17/2006WO2006085688A1 Psychogenic pain therapeutic agent
08/17/2006WO2006085687A1 Composition containing dihomo-ϝ-linolenic acid (dgla) as the active ingredient
08/17/2006WO2006085655A1 Ointment
08/17/2006WO2006085627A1 Cream loaded with shellfish firing product powder and process for producing the same
08/17/2006WO2006085607A1 Plant component-containing emulsion preparation and method for producing the same
08/17/2006WO2006085517A1 Ointment preparation or suppository for pdt based on chlorin or porphyrin derivative
08/17/2006WO2006085143A2 Improved bioactive agent compositions for repair of cell injuries
08/17/2006WO2006084312A1 Method of promoting hair growth
08/17/2006WO2006029182A3 Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases
08/17/2006WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells
08/17/2006US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
08/17/2006US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation
08/17/2006US20060183770 Sulfonamide derivative having isoxazole ring
08/17/2006US20060183760 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors
08/17/2006US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
08/17/2006US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/17/2006US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III
08/17/2006US20060183695 Methods of increasing endogenous erythropoietin (EPO)
08/17/2006US20060183664 Pharmaceutical composition for delayed hypersensitivity
08/17/2006US20060182755 Novel composition and methods for the treatment of psoriasis
08/17/2006US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors
08/17/2006US20060182708 Prebiotically active plant extracts
08/17/2006US20060182688 Metronidazole-based tinted topical pharmaceutical compositions
08/17/2006DE102005005573A1 Hydrophiles Gelsystem zur Hautpflege auf Basis von Karaya-Gummi Hydrophilic gel system for skin care on the basis of karaya gum
08/17/2006DE102005003708A1 Skin care oil, useful as massage oil, for preparing cosmetics to reduce, treat and/or prevent scar tissue, scaly skin, skin stretch marks, skin moisturizing and increasing blood circulation in skin, comprises cocoa butter and jojoba oil
08/17/2006CA2599112A1 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
08/17/2006CA2597537A1 Ointment
08/16/2006EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling
08/16/2006EP1690544A2 Pharmaceutical composition containing decoy and method of using the same
08/16/2006EP1690539A2 Salts of tiotropium for treating inflammatory disorders
08/16/2006EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor
08/16/2006EP1690534A2 Lipoic acid in topical compositions
08/16/2006EP1689864A2 Method and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions
08/16/2006EP1689444A1 Dna delivery with gemini cationic surfactants